{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:59:34Z","timestamp":1772020774565,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"9104","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1016\/s0140-6736(97)09214-3","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T13:37:16Z","timestamp":1027604236000},"page":"700-708","source":"Crossref","is-referenced-by-count":452,"title":["Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial"],"prefix":"10.1016","volume":"351","author":[{"given":"Alan K","family":"Burnett","sequence":"first","affiliation":[]},{"given":"Anthony H","family":"Goldstone","sequence":"additional","affiliation":[]},{"given":"Richard MF","family":"Stevens","sequence":"additional","affiliation":[]},{"given":"Ian M","family":"Hann","sequence":"additional","affiliation":[]},{"given":"John KH","family":"Rees","sequence":"additional","affiliation":[]},{"given":"Richard G","family":"Gray","sequence":"additional","affiliation":[]},{"given":"Keith","family":"Wheatley","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(97)09214-3_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2141.1996.d01-1769.x","article-title":"Dose intensity in acute myeloid leukemia: greater effectiveness at lower cost. Principal report of the MRC's AML 9 Study","volume":"94","author":"Rees","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1182\/blood.V87.5.1710.1710","article-title":"A randomized study of high-dose cytarabine in induction in acute myeloid leukemia","volume":"87","author":"Bishop","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(97)09214-3_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199410063311402","article-title":"Intensive postremission chemotherapy in adults with acute myeloid leukemia","volume":"331","author":"Mayer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(97)09214-3_bib4","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood.V89.7.2311","article-title":"Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukaemia: results of the Medical Research Council's 10th AML Trial (MRC AML 10)","volume":"89","author":"Hann","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(97)09214-3_bib5","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.1985.3.12.1583","article-title":"Intensive induction and consolidation with or without maintenance chemotherapy for acute myeloid leukaemia (AML): two multicenter studies of German AML Cooperative Group","volume":"3","author":"Buchner","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib6","first-page":"243","article-title":"The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation","volume":"2","author":"Clift","year":"1987","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0140-6736(97)09214-3_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V72.1.179.179","article-title":"Chemotherapy v marrow transplantation for adults with acute non-lymphocytic leukemia: a five-year follow-up","volume":"72","author":"Applebaum","year":"1988","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(97)09214-3_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","article-title":"Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulphan and cyclophosphamide","volume":"309","author":"Santos","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(97)09214-3_bib9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(84)91508-3","article-title":"Transplantation of unpurged autologous bone marrow in acute myeloid leukaemia in first remission","volume":"ii","author":"Burnett","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(97)09214-3_bib10","first-page":"267","article-title":"Autologous marrow transplantation in patients with acute non-lymphocytic leukaemia in first remission","volume":"13","author":"Stewart","year":"1985","journal-title":"Exp Haematol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1986.tb02209.x","article-title":"Autologous bone marrow transplantation following high dose therapy for the treatment of adult patients with acute myeloid leukaemia","volume":"64","author":"Goldstone","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1200\/JCO.1990.8.2.287","article-title":"Autologous bone marrow transplantation in acute myeloid leukaemia in first remission: results of a Dutch prospective study","volume":"8","author":"Lowenberg","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib13","first-page":"537","article-title":"Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukemia in first complete remission","volume":"3","author":"Carella","year":"1988","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 3","key":"10.1016\/S0140-6736(97)09214-3_bib14","first-page":"9","article-title":"How to avoid bias when comparing bone marrow transplantation with chemotherapy","volume":"7","author":"Gray","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S0140-6736(97)09214-3_bib15","first-page":"598","article-title":"A simple robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom Medical Research Council (MRC) AML 10 Trial","volume":"86","author":"Wheatley","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(97)09214-3_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199501263320403","article-title":"Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia","volume":"332","author":"Zittoun","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(97)09214-3_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJM199605303342203","article-title":"Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood","volume":"334","author":"Ravidranath","year":"1996","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S0140-6736(97)09214-3_bib18","first-page":"251","article-title":"Prospective comparison of allogeneic bone marrow transplantation, intensive consolidation chemotherapy and unpurged autologous bone marrow transplantation as post remission therapy in adult acute myeloid leukaemia","volume":"84","author":"Harousseau","year":"1994","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/S0140-6736(97)09214-3_bib19","first-page":"232","article-title":"Timing intensive induction therapy improves post-remission outcome in acute myeloid leukemia (AML) irrespective of the use of bone marrow transplantation (BMT)","volume":"84","author":"Woods","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(97)09214-3_bib20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1200\/JCO.1993.11.6.1046","article-title":"Prospective comparative study of bone marrow transplantation and post remission chemotherapy for childhood acute myelogenous leukaemia","volume":"11","author":"Amadori","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2141.1989.tb07652.x","article-title":"Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial","volume":"72","author":"Reiffers","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib22","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V75.8.1606.1606","article-title":"Autologous bone marrow transplantation for acute myelocytic leukaemia in first remission: a European survey of the role of marrow purging","volume":"75","author":"Gorin","year":"1990","journal-title":"Blood"},{"key":"10.1016\/S0140-6736(97)09214-3_bib23","first-page":"762","article-title":"Autotransplants for acute myelogenous leukemia (AML) in North America","volume":"22","author":"Rowlings","year":"1994","journal-title":"Exp Hematol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2141.1993.tb04629.x","article-title":"Factors influencing haematological recovery in 53 patients with acute myeloid leukaemia in first remission after autologous bone marrow transplantation","volume":"83","author":"Pendry","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/S0140-6736(97)09214-3_bib25","first-page":"915","article-title":"Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia","volume":"15","author":"Demirer","year":"1995","journal-title":"Bone Marrow Transplant"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673697092143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673697092143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T17:38:58Z","timestamp":1578505138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673697092143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":25,"journal-issue":{"issue":"9104","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["S0140673697092143"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(97)09214-3","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}